CUFinder

Constantia Pantelidou

Constantia Pantelidou

Harvard University

H-index: 9

North America-United States

Contact Constantia Pantelidou

About Constantia Pantelidou

Constantia Pantelidou, With an exceptional h-index of 9 and a recent h-index of 8 (since 2020), a distinguished researcher at Harvard University, specializes in the field of Translational cancer research, cancer pharmacology, cancer cell biology, drug development.

His recent articles reflect a diverse array of research interests and contributions to the field:

Retraction Note: Polymerase θ inhibition activates the cGAS-STING pathway and cooperates with immune checkpoint blockade in models of BRCA-deficient cancer

RETRACTED ARTICLE: Polymerase θ inhibition activates the cGAS-STING pathway and cooperates with immune checkpoint blockade in models of BRCA-deficient cancer

Abstract C010: Polymerase theta inhibition synergizes with anti-PD-1 immunotherapy in BRCA2-deficient pancreatic ductal adenocarcinoma

STING agonism enhances anti-tumor immune responses and therapeutic efficacy of PARP inhibition in BRCA-associated breast cancer

Bromodomain inhibition reduces CDK6 expression and reverses CDK4/6 inhibitor resistance in ER+ breast cancer

A first-in-class polymerase theta inhibitor selectively targets homologous-recombination-deficient tumors

EZH2 inhibition activates a dsRNA–STING–interferon stress axis that potentiates response to PD-1 checkpoint blockade in prostate cancer

Targeting immunosuppressive macrophages overcomes PARP inhibitor resistance in BRCA1-associated triple-negative breast cancer

Constantia Pantelidou Information

University

Position

Dana Farber Cancer Institute and Harvard Medical School

Citations(all)

1043

Citations(since 2020)

990

Cited By

235

hIndex(all)

9

hIndex(since 2020)

8

i10Index(all)

9

i10Index(since 2020)

8

Email

University Profile Page

Google Scholar

Constantia Pantelidou Skills & Research Interests

Translational cancer research

cancer pharmacology

cancer cell biology

drug development

Top articles of Constantia Pantelidou

Retraction Note: Polymerase θ inhibition activates the cGAS-STING pathway and cooperates with immune checkpoint blockade in models of BRCA-deficient cancer

2023/12/11

Constantia Pantelidou
Constantia Pantelidou

H-Index: 6

RETRACTED ARTICLE: Polymerase θ inhibition activates the cGAS-STING pathway and cooperates with immune checkpoint blockade in models of BRCA-deficient cancer

Nature Communications

2023/3/13

Constantia Pantelidou
Constantia Pantelidou

H-Index: 6

Abstract C010: Polymerase theta inhibition synergizes with anti-PD-1 immunotherapy in BRCA2-deficient pancreatic ductal adenocarcinoma

Cancer Research

2022/11/15

Constantia Pantelidou
Constantia Pantelidou

H-Index: 6

Jie Hao
Jie Hao

H-Index: 8

STING agonism enhances anti-tumor immune responses and therapeutic efficacy of PARP inhibition in BRCA-associated breast cancer

NPJ Breast Cancer

2022/9/6

Constantia Pantelidou
Constantia Pantelidou

H-Index: 6

Bromodomain inhibition reduces CDK6 expression and reverses CDK4/6 inhibitor resistance in ER+ breast cancer

Cancer Research

2022/6/15

Constantia Pantelidou
Constantia Pantelidou

H-Index: 6

A first-in-class polymerase theta inhibitor selectively targets homologous-recombination-deficient tumors

Nature cancer

2021/6

Jia Zhou
Jia Zhou

H-Index: 12

Constantia Pantelidou
Constantia Pantelidou

H-Index: 6

Adam Li
Adam Li

H-Index: 4

EZH2 inhibition activates a dsRNA–STING–interferon stress axis that potentiates response to PD-1 checkpoint blockade in prostate cancer

Nature cancer

2021/4

Yin Liu
Yin Liu

H-Index: 2

Xintao Qiu
Xintao Qiu

H-Index: 13

Kevin Roehle
Kevin Roehle

H-Index: 3

Carla Calagua
Carla Calagua

H-Index: 6

Huihui Ye
Huihui Ye

H-Index: 21

Constantia Pantelidou
Constantia Pantelidou

H-Index: 6

Atish D Choudhury
Atish D Choudhury

H-Index: 15

Housheng Hansen He
Housheng Hansen He

H-Index: 32

Massimo Loda
Massimo Loda

H-Index: 76

Targeting immunosuppressive macrophages overcomes PARP inhibitor resistance in BRCA1-associated triple-negative breast cancer

Nature cancer

2021/1

Constantia Pantelidou
Constantia Pantelidou

H-Index: 6

Jia-Ren Lin
Jia-Ren Lin

H-Index: 18

Marian Kalocsay
Marian Kalocsay

H-Index: 10

Mikel Lipschitz
Mikel Lipschitz

H-Index: 10

Scott Rodig
Scott Rodig

H-Index: 90

Sandro Santagata
Sandro Santagata

H-Index: 53

860 Targeting immunosuppressive macrophages overcomes PARP-inhibitor resistance in BRCA1-associated triple-negative breast cancer

2020/11/1

Constantia Pantelidou
Constantia Pantelidou

H-Index: 6

Jia-Ren Lin
Jia-Ren Lin

H-Index: 18

Nathan Johnson
Nathan Johnson

H-Index: 1

William Oldham
William Oldham

H-Index: 17

Marian Kalocsay
Marian Kalocsay

H-Index: 10

Mikel Lipschitz
Mikel Lipschitz

H-Index: 10

Scott Rodig
Scott Rodig

H-Index: 90

Sandro Santagata
Sandro Santagata

H-Index: 53

Judy Garber
Judy Garber

H-Index: 52

Jennifer Guerriero
Jennifer Guerriero

H-Index: 16

Abstract A105: PARP inhibition modulates the infiltration, phenotype, and function of tumor-associated macrophages (TAMs) in BRCA-associated breast cancer and can be augmented …

Cancer Immunology Research

2020/3/1

Jia-Ren Lin
Jia-Ren Lin

H-Index: 18

Marian Kalocsay
Marian Kalocsay

H-Index: 10

Constantia Pantelidou
Constantia Pantelidou

H-Index: 6

Sandro Santagata
Sandro Santagata

H-Index: 53

Abstract P5-04-01: PARP inhibition modulates the infiltration, phenotype and function of tumor-associated macrophages (TAMs) in BRCA-associated breast cancer and can be …

Cancer Research

2020/2/15

Jia-Ren Lin
Jia-Ren Lin

H-Index: 18

Constantia Pantelidou
Constantia Pantelidou

H-Index: 6

Marian Kalocsay
Marian Kalocsay

H-Index: 10

Dan Wang
Dan Wang

H-Index: 17

Mikel Lipschitz
Mikel Lipschitz

H-Index: 10

Scott Rodig
Scott Rodig

H-Index: 90

Sandro Santagata
Sandro Santagata

H-Index: 53

See List of Professors in Constantia Pantelidou University(Harvard University)